Ondine Biomedical Inc., a Canadian-headquartered company led by founder and CEO Carolyn Cross, alleges a ransomware incident attributed to the threat actor incransom, with claims of data exposure and forthcoming disclosures next week. The company notes that its patented photodisinfection technology platform—not yet approved in the United States—is among the information reportedly affected, and says it will publish all details next week #Canada
Incident Details
- Victim: Ondine Biomedical
- Sector: Healthcare
- Country: CA
- Actor: incransom
- Source: http://incblog6qu4y4mm4zvw5nrmue6qbwtgjsxpw6b7ixzssu36tsajldoad.onion/blog/disclosures/6991a8838f1d14b743c5c963
- Discovered: 2026-02-16 09:39:36.590224
- Published: 2026-02-16 01:00:00.000000
Information
- Ondine Biomedical Inc., Canadian-headquartered company led by founder and CEO Carolyn Cross.
- Developed a patented photodisinfection technology platform for treatment and prevention therapies targeting a broad spectrum of pathogens, including multidrug-resistant strains.
- Photodisinfection is not currently approved in the United States.
- Ransomware actor involved: incransom.
- All information will be published next week.
Disclaimer: This post is based on public claims made by the ransomware group "incransom". I cannot confirm the accuracy of the information. However, I would be happy to share any official statement from the affected organization to provide clarification.